TRULY
focused on
Rare (orphan) Diseases
Orphanbiotec AG is a socially responsible, research-based
pharmaceutical enterprise specializing in Rare Diseases.
Enabled by our partners, we build bridges for people in need
and affordable health care of the future.
IMPLICT
social
commitment
Orphanbiotec AG is a socially responsible, research-based
pharmaceutical enterprise specializing in Rare Diseases.
Enabled by our partners, we build bridges for people in need
and affordable health care of the future.
ESTABLISHING
treatments
based on natural principles
Orphanbiotec AG is a socially responsible, research-based
pharmaceutical enterprise specializing in Rare Diseases.
Enabled by our partners, we build bridges for people in need
and affordable health care of the future.
SUSTAINABLE
financial
impact
Orphanbiotec AG is a socially responsible, research-based
pharmaceutical enterprise specializing in Rare Diseases.
Enabled by our partners, we build bridges for people in need
and affordable health care of the future.
Orphanbiotec works on the development and implementation of new medications for Rare Diseases. Our nature based pharmaceutical solutions create affordable therapies for Rare Diseases in a sustainable and profitable manner through the repositioning of approved substances. The company was founded in January 2009. Orphanbiotec AG is a Swiss Start-up company, which works in a unique hybrid partnership with the charitable Foundation Orphanhealthcare.
Orphanbiotec engages in delivering sustainable, financial and social impact to patients & investors.
We develop innovative and affordable Orphan Drugs for diagnosis and therapy of Rare Diseases.
Rare means nearly 5 out of 10.000 healthy individuals can be affected. So rare is not rare, since more than 7000 diseases are know today and approx. In Europe there are 30 M people living with a rare disease. About 75 % out of them are children.
How do we generate our impact.
We are approaching active principles present in nature. Many are used for generations by healer or complementary treatments and safe, but underestimated for additional and useful effects. And many of the natural principles are not even discovered yet.
We are proud to be winner of: